Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
RBP-01 in Uveal Melanoma: NCT07747935 Clinical Landscape Report 2026
11 September 2026
NCT07747935 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GS1191-0445 in Hemophilia A: NCT07548411 Clinical Landscape Report 2026
11 September 2026
NCT07548411 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enlonstobart in Locally Advanced Rectal Carcinoma: NCT07810114 Clinical Landscape Report 2026
11 September 2026
NCT07810114 clinical landscape for Locally Advanced Rectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
TUB-040 in Recurrent Endometrial Cancer: NCT07743541 Clinical Landscape Report 2026
11 September 2026
NCT07743541 clinical landscape for Recurrent Endometrial Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nalbuphine Hydrochloride in Idiopathic Pulmonary Fibrosis: NCT07671911 Clinical Landscape Report 2026
11 September 2026
NCT07671911 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VTRU-200 in High Risk Myelodysplastic Syndrome: NCT07749976 Clinical Landscape Report 2026
11 September 2026
NCT07749976 clinical landscape for High Risk Myelodysplastic Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
R01 in Advanced Lung Squamous Cell Carcinoma: NCT07806500 Clinical Landscape Report 2026
11 September 2026
NCT07806500 clinical landscape for Advanced Lung Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
CT-179 in Recurrent Glioblastoma: NCT07739017 Clinical Landscape Report 2026
11 September 2026
NCT07739017 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MWN105 in Diabetes Mellitus, Type 2: NCT07801313 Clinical Landscape Report 2026
11 September 2026
NCT07801313 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Non-Muscle Invasive Bladder Neoplasms: NCT07747740 Clinical Landscape Report 2026
11 September 2026
NCT07747740 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Dupilumab Biosimilar (Innovent Biologics) in Dermatitis, Atopic: NCT07754786 Clinical Landscape Report 2026
11 September 2026
NCT07754786 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GB-0895 in Severe asthma: NCT07276724 Clinical Landscape Report 2026
11 September 2026
NCT07276724 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.